Clinical implementation of pharmacogenetics.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- García-González X
- Cabaleiro T
- McLeod H
- López-Fernández LA
Grupos
Abstract
In the last decade, pharmacogenetic research has been performed in different fields. However, the application of pharmacogenetic findings to clinical practice has not been as fast as desirable. The current situation of clinical implementation of pharmacogenetics is discussed. This review focuses on the advances of pharmacogenomics to individualize cancer treatments, the relationship between pharmacogenetics and pharmacodynamics in the clinical course of transplant patients receiving a combination of immunosuppressive therapy, the needs and barriers facing pharmacogenetic clinical application, and the situation of pharmacogenetic testing in Spain. It is based on lectures presented by speakers of the Clinical Implementation of Pharmacogenetics Symposium at the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society, held in April 20, 2015.
Datos de la publicación
- ISSN/ISSNe:
- 2363-8915, 2363-8915
- Tipo:
- Article
- Páginas:
- 9-16
- PubMed:
- 26751902
- Factor de Impacto:
- 0,427 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Drug metabolism and personalized therapy Walter de Gruyter GmbH
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Proyectos y Estudios Clínicos
CONTRATOS DE TECNICOS DE APOYO A LA INVESTIGACION EN EL SISTEMA NACIONAL DE SALUD
CA12/00052 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
PLATAFORMA DE UNIDADES DE INVESTIGACION CLINICA Y ENSAYOS CLINICOS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
PT13/0002/0032 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014
COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.
Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO
PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014
ESTUDIO FARMACOGENÉTICO DEL TRATAMIENTO EN LA INSUFICIENCIA CARDIACA TERMINAL: INHIBIDORES DE LA ECA, B-BLOQUEANTES Y ANTIALDOSTERÓNICOS.
Investigador Principal: MARÍA JOSÉ HERRERO CERVERA
HLF-ECA-2015-01
Cita
García X,Cabaleiro T,HERRERO MJ,McLeod H,López LA. Clinical implementation of pharmacogenetics. Drug Metab Pers Ther. 2016. 31. (1):p. 9-16.